9 results
Current guidelines for outpatient treatment of Community Acquired Pnemonia (CAP)

#Management #Outpatient #CAP #Community #Acquired #Pneumonia #Antibiotics
of Community Acquired ... Pnemonia (CAP) ... #Management #Outpatient ... #CAP #Community ... #Antibiotics #Treatment
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Treatment Options ... Ventilator-Associated Pneumonia ... /Gram-Negative Coverage ... Are Appropriate #Management ... #Antibiotics #VAP
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Pneumonia (CAP) ... #Pneumonia #Antibiotics ... #Management #Guidelines ... #pharmacology
Antibiotics for severe community-onset pneumonia 

Atypical coverage always 

- Usually azithromycin 500 mg daily 

- Doxycycline
severe community-onset ... pneumonia Atypical ... #Acquired #Pneumonia ... #CAP #Antibiotics ... #Coverage #Management
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... acquired pneumonia ... acquired pneumonia ... #management #durations ... #pharmacology #
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... Pneumonia (CAP) ... RESPIRATORY 96.1% • Empiric ... antibiotic therapy ... #Management #treatment
Emphysematous Cystitis
Epidemiology:
 • Usually middle-aged diabetic women
 • Other RF: neurogenic bladder, urinary tract outlet obstruction,
lactulose producing gas ... clostridium, klebsiella pneumoniae ... also important Management ... : • Empiric antibiotics ... data • Early treatment
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Ciprofloxacin (~70% coverage ... used as double coverage ... monotherapy for empiric ... Pseudomonas treatment ... Polymyxin B(IV) #Pharmacology
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... pneumonia, sinusitis ... Ceftriaxone for CAP ... Used for MAC treatment ... #Pharmacology #Antibiotics